CIRILLO, EMILIA
 Distribuzione geografica
Continente #
AS - Asia 3.161
NA - Nord America 2.526
EU - Europa 2.498
SA - Sud America 430
AF - Africa 85
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 5
Totale 8.710
Nazione #
US - Stati Uniti d'America 2.421
SG - Singapore 1.697
RU - Federazione Russa 1.391
CN - Cina 746
IT - Italia 381
BR - Brasile 339
VN - Vietnam 292
HK - Hong Kong 213
DE - Germania 173
FI - Finlandia 88
FR - Francia 75
GB - Regno Unito 72
IE - Irlanda 66
NL - Olanda 63
IN - India 58
CA - Canada 55
SE - Svezia 47
UA - Ucraina 47
MX - Messico 41
AR - Argentina 34
TR - Turchia 29
CI - Costa d'Avorio 24
AT - Austria 23
EC - Ecuador 23
KR - Corea 23
PL - Polonia 23
ZA - Sudafrica 23
ES - Italia 15
ID - Indonesia 15
JP - Giappone 15
IQ - Iraq 14
CO - Colombia 12
EG - Egitto 12
BD - Bangladesh 11
KE - Kenya 7
UZ - Uzbekistan 7
BE - Belgio 6
LT - Lituania 6
MA - Marocco 6
PY - Paraguay 6
AE - Emirati Arabi Uniti 5
IL - Israele 5
PE - Perù 5
AU - Australia 4
DK - Danimarca 4
EU - Europa 4
KZ - Kazakistan 4
CH - Svizzera 3
CR - Costa Rica 3
OM - Oman 3
TN - Tunisia 3
UY - Uruguay 3
VE - Venezuela 3
AZ - Azerbaigian 2
CL - Cile 2
CY - Cipro 2
DZ - Algeria 2
ET - Etiopia 2
GR - Grecia 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
NP - Nepal 2
PS - Palestinian Territory 2
SA - Arabia Saudita 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AD - Andorra 1
AL - Albania 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BO - Bolivia 1
CD - Congo 1
CW - ???statistics.table.value.countryCode.CW??? 1
GE - Georgia 1
GF - Guiana Francese 1
GY - Guiana 1
HR - Croazia 1
JM - Giamaica 1
JO - Giordania 1
LB - Libano 1
LC - Santa Lucia 1
LV - Lettonia 1
MT - Malta 1
MW - Malawi 1
MY - Malesia 1
PA - Panama 1
PG - Papua Nuova Guinea 1
PH - Filippine 1
PK - Pakistan 1
PT - Portogallo 1
QA - Qatar 1
RO - Romania 1
SO - Somalia 1
SY - Repubblica araba siriana 1
TZ - Tanzania 1
UG - Uganda 1
Totale 8.710
Città #
Singapore 812
Chandler 363
Moscow 329
Beijing 262
Santa Clara 228
Ashburn 216
Hong Kong 204
Hefei 140
Dong Ket 80
Los Angeles 76
Ho Chi Minh City 73
Millbury 72
Napoli 53
Nanjing 51
Princeton 50
Boston 47
Wilmington 41
Hanoi 40
Jacksonville 40
Amsterdam 38
Munich 37
Naples 37
The Dalles 36
Des Moines 35
San Jose 34
Buffalo 33
Dallas 33
Redondo Beach 33
Frankfurt am Main 32
New York 32
São Paulo 32
Houston 27
Seattle 26
Helsinki 23
London 23
Seoul 23
Brooklyn 21
Lawrence 19
Milan 19
Orem 19
Ottawa 19
Mexico City 18
Nuremberg 18
Warsaw 18
Falkenstein 17
Turku 17
Atlanta 16
Düsseldorf 15
Montreal 15
Nanchang 15
Poplar 15
Pune 15
Rome 15
Boardman 14
Chicago 14
Tokyo 14
Woodbridge 14
Chennai 13
Haiphong 13
Phoenix 13
Rio de Janeiro 13
Falls Church 12
Quito 12
Dublin 11
Tianjin 11
Vienna 11
Hebei 10
Manchester 10
Da Nang 9
Denver 9
Kochi 9
Stockholm 9
Belo Horizonte 8
Castellana Grotte 8
Querétaro 8
Roubaix 8
Toronto 8
Cairo 7
Lauterbourg 7
Nairobi 7
Neenah 7
Thái Bình 7
Baghdad 6
Biên Hòa 6
Changsha 6
Fairfield 6
Lấp Vò 6
Porto Alegre 6
Shenyang 6
Tashkent 6
Xi'an 6
Afragola 5
Brasília 5
Curitiba 5
Guangzhou 5
Guayaquil 5
Johannesburg 5
Lappeenranta 5
Medellín 5
Pozzuoli 5
Totale 4.397
Nome #
DiGeorge-like syndrome in a child with a 3p12.3 deletion involving miRNA-4273 born to a diabetic mother 216
De novo 13q12.3q14.11 deletion involving BRCA2 gene in a patient with developmental delay, elevated IgM levels, transient ataxia and cerebellar hypoplasia, mimicking an A-T like phenotype. 165
Clinical, Immunological, and Functional Characterization of Six Patients with Very High IgM Levels 150
Intrathecal amphotericin B therapy in a patient with X-linked chronic granulomatous disease and refractory cerebral invasive aspergillosis 140
Chronic mucocutaneous candidiasis, recurrent herpetic infections and suppurative eyelid infections in a patient carrying a novel gain-of-function mutation in the STAT1 DNA-binding domain 138
TLR9 signaling in patients with ectodermal dysplasia and immunodeficiency associated with Nuclear Factor Essential Modulator (NEMO) mutations 138
Steroid treatment in Ataxia-Telangiectasia induces alterations of functional magnetic resonance imaging during prono-supination task. 136
DiGeorge-like Syndrome in a Child with a 3p12.3 Deletion Involving MIR4273 Gene Born to a Mother with Gestational Diabetes Mellitus 134
Gastrointestinal involvement in patients affected with 22q11.2 deletion syndrome 131
CD4+ T Cell Defects in a Mulibrey Patient With Specific TRIM37 Mutations 128
The Inborn Errors of Immunity—Virtual Consultation System Platform in Service for the Italian Primary Immunodeficiency Network: Results from the Validation Phase 125
The Impact of SARS-CoV-2 Infection in Patients with Inborn Errors of Immunity: the Experience of the Italian Primary Immunodeficiencies Network (IPINet) 125
Novel STAT1 gain of function mutation and suppurative infections 123
Vaccination in immunocompromised host: Recommendations of Italian Primary Immunodeficiency Network Centers (IPINET) 120
Follicular helper T cell signature of replicative exhaustion, apoptosis, and senescence in common variable immunodeficiency 120
Phenotypic characterization and outcome of paediatric patients affected with haemophagocytic syndrome of unknown genetic cause. 117
Severe combined immunodeficiency-an update 116
Clinical, Immunological, and Molecular Features of Typical and Atypical Severe Combined Immunodeficiency: Report of the Italian Primary Immunodeficiency Network 116
Case report: EBV-related eye orbits and sinuses lymphohistiocytic infiltration responsive to rituximab in a patient with X lymphoproliferative syndrome type 1 113
Intergenerational and intrafamilial phenotypic variability in 22q11.2 deletion syndrome subjects 113
Diagnostics of Primary immunodeficiencies through next-generation sequencing 112
Otolarylogical features in a cohort of patients affected with 22q11.2 deletion syndrome: a monocentric survey 112
X-linked lymphoproliferative disease due to SAP/SH2D1A deficiency: a multicenter study on the manifestations, management, and outcome of the disease. 111
Immunodeficienze primitive: cosa c’è di nuovo 111
Progressive Depletion of B and T Lymphocytes in Patients with Ataxia Telangiectasia: Results of the Italian Primary Immunodeficiency Network 111
Unraveling the link between ectodermal disorders and primary immunodeficiencies 110
Understanding the Variability of 22q11.2 Deletion Syndrome: The Role of Epigenetic Factors 109
Severe combined immunodeficiences: new and old scenarios 109
Unbalanced Immune System: Immunodeficiencies and Autoimmunity 109
Altered signaling through IL-12 receptor in children with very high serum IgE levels 108
Long-term follow-up of 168 patients with X-linked agammaglobulinemia reveals increased morbidity and mortality 108
Consensus of the Italian Primary Immunodeficiency Network on transition management from pediatric to adult care in patients affected with childhood-onset inborn errors of immunity 107
In Ataxia-Telangiectasia, Oral Betamethasone Administration Ameliorates Lymphocytes Functionality through Modulation of the IL-7/IL-7Rα Axis Paralleling the Neurological Behavior: A Comparative Report of Two Cases 106
Intergenerational familial phenotipic variability in 22Q11.2 subjects: a multicenter study within the italian primary immunodeficiencies network (IPINET) 105
Health-Related Quality of Life and Emotional Difficulties in Chronic Granulomatous Disease: Data on Adult and Pediatric Patients from Italian Network for Primary Immunodeficiency (IPINet) 105
A Nationwide Study of GATA2 Deficiency in Italy Reveals Novel Symptoms and Genotype–phenotype Association 104
Efficacy of very-low-dose betamethasone on neurological symptoms in ataxia-telangiectasia 103
DiGeorge Syndrome 102
Genetic basis of altered central tolerance and autoimmune diseases: a lesson from AIRE mutations 101
Complement system network in cell physiology and in human diseases 101
Evaluation of executive functions in subjects affected with 22Q11.2 deletion syndrome: a neuroanatomical hypothesis 100
Elevated IgM levels in a patient with a de novo 13Q12.3Q14.11 deletion, mimicking an A-T like phenotype 100
FOXN1 Deficiency: from the Discovery to Novel Therapeutic Approaches 100
Minimum effective betamethasone dosage on the neurological phenotype in patients with Ataxia-Telangiectasia: a multicenter observer-blind study 99
Follow-up and outcome of symptomatic partial or absolute IgA deficiency in children 98
Rare solid tumors in a patient with Wiskott–Aldrich syndrome after hematopoietic stem cell transplantation: case report and review of literature 97
A novel form of hyper-IgM syndrome 97
Clinical Phenotype, Immunological Abnormalities, and Genomic Findings in Patients with DiGeorge Spectrum Phenotype without 22q11.2 Deletion 97
Chronic granulomatous disease with gastrointestinal presentation: diagnostic pitfalls and novel ultrastructural findings 96
A Bronchovascular Anomaly in a Patient With 22q11.2 Deletion Syndrome 96
Novel Findings into AIRE Genetics and Functioning: Clinical Implications 95
Consensus of the Italian Primary Immunodeficiency Network on the use and interpretation of genetic testing for diagnosing inborn errors of immunity 94
SCID-like phenotype associated with an inhibitory autoreactive immunoglobulin 94
Retrospective analysis of 21 pediatric patients affected with hemophagocytic syndrome of unknown genetic cause: clinical features and outcome 94
Mechanisms of immune tolerance breakdown in inborn errors of immunity 93
Epigenetic Alterations in Inborn Errors of Immunity 93
Long term longitudinal follow-up of an AD-HIES cohort: the impact of early diagnosis and enrollment to IPINet centers on the natural history of Job’s syndrome 91
Respiratory Manifestations in Primary Immunodeficiencies: Findings From a Pediatric and Adult Cohort 91
NADPH Oxidase Deficiency: A Multisystem Approach 90
Clinical Manifestations of 22q11.2 Deletion Syndrome 89
In ataxia-Telangiectasia betamethasone response correlates inversely to cerebellar atrophy and directly to antioxidative capacity 88
SARS-CoV-2 Infection in the Immunodeficient Host: Necessary and Dispensable Immune Pathways 88
T-Cell Immunodeficiencies With Congenital Alterations of Thymic Development: Genes Implicated and Differential Immunological and Clinical Features 86
Cutaneous vasculitis in patients with autoimmune polyendocrine syndrome type 1: report of a case and brief review of the literature 85
Neonatal alloimmune neutropenia: diagnosis and management of 31 Italian patients 82
Estimate the minimum therpeutically effective dosage of short-term therapy with Betamethasone on neurologicaal symptoms in patients affected with Ataxia-Telangectasia 82
MicroRNA dysregulation in ataxia telangiectasia 80
Clinical Features and Follow-Up in Patients with 22q11.2 Deletion Syndrome 80
Three Unrelated Patients of Roma Ethnicity from a Single Center Carrying the Same Deletion in MYD88 Gene: A Founder Effect? 77
A case of Incontinentia Pigmenti associated with congenital absence of portal vein system and nodular regenerative hyperplasia 77
Characterization of a WAS splice-site variant in a patient with Wiskott-Aldrich syndrome 76
B cells from nuclear factor kB essential modulator deficient patients fail to differentiate to antibody secreting cells in response to TLR9 ligand 76
Two Brothers with Atypical UNC13D-Related Hemophagocytic Lymphohistiocytosis Characterized by Massive Lung and Brain Involvement 76
The effects of betamethasone therapy on neurological functions in A-T patients 75
Challenges in investigating patients with isolated decreased serum IgM: The SIMcal study 75
In Ataxia-Teleangectasia betamethasone response correlates inversely to cerebellar atrophy and directly to antioxidative capacity. 74
Gamma chain transducing element: a shared pathway between endocrine and immune system 73
Intergenerational anticipation of disease onset in people with multiple autoimmune syndrome. 72
Reduced atherosclerotic burden in subjects with genetically determined low oxidative stress 72
Case Report: Severe Rhabdomyolysis and Multiorgan Failure After ChAdOx1 nCoV-19 Vaccination 72
In adult X-CGD patients, regulatory T cells are expanded while activated T cells display a NOX2-independent ROS increase 70
Estimate the minimum therapeutically effective dosage of short term therapy with betamethasone on neurological symptoms in patients affected with Ataxia- Teleangectasia 68
Immunological Aspects of Kabuki Syndrome: A Retrospective Multicenter Study of the Italian Primary Immunodeficiency Network (IPINet) 68
Allergic Manifestations of Inborn Errors of Immunity 63
A novel pathogenic variant causing POU3F3-related neurodevelopmental disorder in a child presenting with infantile epileptic spasms syndrome: Expanding the epileptic phenotype 61
Different Degrees of NADPH Oxidase 2 Regulation and In Vivo Platelet Activation: Lesson From Chronic Granulomatous Disease 58
Expanding the Nude SCID/CID Phenotype Associated with FOXN1 Homozygous, Compound Heterozygous, or Heterozygous Mutations 53
Oral thrush and onychomycosis 51
In ataxia-teleangiectasia betamethasone response is inversely correlated to cerebellar atrophy and directly to antioxidative capacity. 45
Development of cancer surveillance guidelines in ataxia telangiectasia: A Delphi‐based consensus survey of international experts 39
Recurrent cold suppurative granulomatous lymphadenitis 35
Totale 8.889
Categoria #
all - tutte 28.474
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.474


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021141 0 0 0 0 0 0 9 7 15 5 23 82
2021/2022448 10 0 1 7 4 15 1 17 75 49 110 159
2022/2023696 79 86 15 79 100 81 1 58 118 31 35 13
2023/2024404 12 63 34 26 26 38 8 46 31 10 81 29
2024/20252.998 119 134 20 23 109 240 227 207 190 314 1.156 259
2025/20263.442 574 436 586 543 1.051 215 37 0 0 0 0 0
Totale 8.889